Ascent Biomedical Ventures

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$30.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Motus GI
Colon Cleansing for Colonoscopy
1 round $30.0M committed Latest: 2017-02

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Ascent Biomedical Ventures' most notable exit?
Ascent Biomedical Ventures notably exited Motus GI in February 2018 through a Public Offering (POEvent) on NASDAQ. Motus GI had raised $17.5M in capital prior to this exit.
Which sector does Ascent Biomedical Ventures primarily focus on for investments?
Ascent Biomedical Ventures focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Can you name a key company in Ascent Biomedical Ventures' portfolio?
A key company in Ascent Biomedical Ventures' portfolio is Motus GI, which operates in the B2B business model focusing on colon cleansing for colonoscopy.
When was Ascent Biomedical Ventures' most recent investment activity?
Ascent Biomedical Ventures' most recent recorded investment activity was in February 2017, with one new portfolio company added that month.
What is the total capital raised by Motus GI, a company in Ascent Biomedical Ventures' portfolio?
Motus GI, a company in Ascent Biomedical Ventures' portfolio, has raised $64.5M and is currently in the Public funding stage.